All stock lists
PENTAIR plc (New York Stock Exchange:PNR)
GB · Delayed Price · Currency is USD
55.30+0.13 (+0.24%)
Insider Score
––Not scored
PNR Insider Score
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
PNR analyst forecast
PNR analyst consensus
Moderate Buy8 ratings
Buy 5 Hold 3 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
PNR 12-month price target
$78.33+41.2% upsideaverage of 3 firms
$91.00High
$60.00Low
Best analysts covering PNR
- TD Cowen100%success rate · 3 calls
- B of A Securities100%success rate · 1 call
- Oppenheimer83%success rate · 12 calls
- Stifel83%success rate · 12 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
PNR analyst ratings
| Analyst | Firm | Rating | Price target | Upside | Action | Date |
|---|---|---|---|---|---|---|
| Oppenheimer | Outperform | $84.00 | +58.9% | Reiterated | 2026-10-21 | |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-10-15 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-10-14 |
| — | TD Cowen | Hold | — | — | Upgraded | 2026-10-14 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-10-12 |
| Goldman Sachs | Neutral | $60.00 | +14.7% | Reiterated | 2026-10-09 | |
| Wolfe Research | Outperform | $91.00 | +62.0% | Upgraded | 2026-09-15 | |
| — | TD Cowen | Sell | — | — | Reiterated | 2026-07-29 |
| — | Baird | Outperform | — | — | Reiterated | 2026-07-29 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-07-21 |
| — | BNP Paribas | Underperform | — | — | Reiterated | 2026-07-16 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-07-16 |
| — | Stifel | Hold | — | — | Downgraded | 2026-07-16 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-07-16 |
| — | Seaport Global | Neutral | — | — | Downgraded | 2026-07-15 |
| — | RBC Capital | Sector Perform | — | — | Downgraded | 2026-07-15 |
| — | Baird | Outperform | — | — | Reiterated | 2026-07-15 |
| — | Wolfe Research | Peer Perform | — | — | Downgraded | 2026-07-09 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-04-29 |
| — | TD Cowen | Sell | — | — | Reiterated | 2026-04-29 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-04-29 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-04-29 |
| — | Stifel | Buy | — | — | Reiterated | 2026-04-29 |
| — | Seaport Global | Buy | — | — | Reiterated | 2026-04-29 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-04-29 |
| — | B of A Securities | Underperform | — | — | Reiterated | 2026-04-20 |
| — | Stifel | Buy | — | — | Reiterated | 2026-04-14 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-04-13 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-04-01 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-02-04 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-02-04 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-01-16 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-01-12 |
| — | BNP Paribas Exane | Underperform | — | — | Downgraded | 2026-01-07 |
| — | TD Cowen | Sell | — | — | Downgraded | 2026-01-05 |
| — | Jefferies | Buy | — | — | Upgraded | 2025-12-10 |
| — | Barclays | Equal Weight | — | — | Downgraded | 2025-12-04 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-11-20 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-10-22 |
| — | UBS | Buy | — | — | Reiterated | 2025-10-22 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-10-22 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-10-20 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-10-15 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-10-09 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-10-01 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2025-07-29 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-07-23 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-07-23 |
| — | TD Cowen | Hold | — | — | Downgraded | 2025-07-23 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-07-23 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-07-23 |
| — | Baird | Outperform | — | — | Reiterated | 2025-07-23 |
| — | Stifel | Buy | — | — | Reiterated | 2025-07-21 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-07-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-07-09 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2025-05-16 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2025-04-23 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-04-23 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-04-23 |
| — | UBS | Buy | — | — | Reiterated | 2025-04-23 |
PNR earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-03 | 1.17 | 1.18 | $1.01B | $1.02B |
| 2026-04-28 | 1.17 | 1.22 | $1.03B | $1.04B |
| 2026-07-28 | 1.12 | 1.14 | $943.2M | $932.6M |
| 2026-10-27 | 1.07 | 0.00 | $963.7M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.